Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device

German cardiovascular care accounts for every sixth Euro:

This article was originally published in Clinica

  • News

Executive Summary

The treatment of cardiovascular (CV) diseases in Germany cost the health service some Euros35.4bn ($43.6bn) in 2002, the latest figures from the federal department for statistics (destatis) reveal. This accounted for 15.8% of the total Euros223.6bn expenditure on healthcare. Euros8.1bn was spent on treating high blood pressure and Euros7.8bn on cerebrovascular conditions, including stroke (Euros2bn) and brain infarct (Euros2bn). The cost of treating ischaemic heart conditions, including angina pectoris and heart infarction, amounted to Euros7bn. The figures have been released following a restructuring of the healthcare cost calculation mechanism has allowed destatis for the first time to display costs according to illness and age.

Table

View full table

Topics

Tags:
Medical Device
Latest Headlines

Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease

Small Sterilization Companies Poised To Meet EtO Emissions Goals On Time

At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use

UK MHRA Updates Assistive Tech And Borderline Regulations

See All
UsernamePublicRestriction

Register

MT059079

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By